Supraclavicular Lymphadenopathy: Should It Be Perceived as the Virchow's Node of Head and Neck Tumors?
- 21 November 2014
- journal article
- Published by S. Karger AG in Oncology Research and Treatment
- Vol. 37 (12) , 726-730
Abstract
Background: In this study, we aimed to determine the correlation between supraclavicular lymph node involvement (SLNI) and metastatic potential, frequency, and metastases predilection sites in patients diagnosed with various head and neck tumors (HNT) and staged via positron emission tomography/computed tomography (PET/CT) imaging. We also investigated the impact of different variables on SLNI. Patients and Methods: 270 patients diagnosed with HNT were enrolled in the study (194 males and 96 females, mean age 54.9 ± 14.7 years (range 18-89 years)). Results: Nasopharyngeal carcinoma demonstrated significant SLNI (p < 0.01); however, other subtypes of HNT did not. In all HNT studied, no apparent metastatic predilection tendency for the supraclavicular region was observed, as opposed to the well-described Virchow's node. Age, gender, tumor size, and systemic metastases were not identified as statistically significant variables contributing to SLNI. Multivariate regression analysis revealed an increased cervical (p < 0.01) and thoracic (p = 0.001) lymph node involvement in patients with SLNI. Conclusion: SLNI with the possibility of metastasis was more frequently observed in nasopharyngeal carcinoma, advancing the nodal status without significantly influencing the T and M stages. A careful evaluation of this very small region is of critical importance for proper nodal staging in nasopharyngeal cancer patients.Keywords
This publication has 16 references indexed in Scilit:
- Supraclavicular Lymph Nodes Detected by 18F-FDG PET/CT in Cancer Patients: Assessment With 18F-FDG PET/CT and SonographyAmerican Journal of Roentgenology, 2012
- FDG-PET staging and importance of lymph node SUV in head and neck cancerHead & Neck Oncology, 2010
- Making sense of post-treatment surveillance in head and neck cancer: when and what of follow-upCancer Treatment Reviews, 2009
- Current State of Neck Dissection in the United StatesHead and Neck Pathology, 2009
- Adjuvant Radiotherapy and Survival for Patients With Node-Positive Head and Neck Cancer: An Analysis by Primary Site and Nodal StageInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- 2-[18F]-Fluoro-2-deoxy-d-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynxEuropean Journal of Surgical Oncology, 2007
- Impact of [18F]‐2‐Fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography on Previously Untreated Head and Neck Cancer PatientsThe Laryngoscope, 2007
- Impact of FDG-PET/CT Imaging on Nodal Staging for Head-And-Neck Squamous Cell CarcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Imaging of Cervical Lymph Nodes in Head and Neck Cancer: The BasicsRadiologic Clinics of North America, 2006
- Screening for Distant Metastases in Patients With Head and Neck CancerThe Laryngoscope, 2000